Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	45,427	24,243	18,858	24,266	14,979	11,060	Upgrade
Market Cap Growth	90.54%	28.56%	-22.29%	62.00%	35.43%	14.08%	Upgrade
Enterprise Value	45,463	24,200	19,060	24,537	14,677	10,722	Upgrade
Last Close Price	343.21	190.55	151.59	191.34	119.22	99.03	Upgrade
PS Ratio	19.02	13.50	13.14	28.18	24.02	30.64	Upgrade
PB Ratio	261.07	452.40	-108.87	-184.79	34.48	14.86	Upgrade
P/TBV Ratio	261.07	452.40	-	-	34.48	14.86	Upgrade
P/FCF Ratio	275.85	-	572.67	-	-	-	Upgrade
P/OCF Ratio	229.68	-	230.62	-	-	-	Upgrade
EV/Sales Ratio	18.87	13.48	13.28	28.50	23.54	29.70	Upgrade
EV/FCF Ratio	276.07	-	578.81	-	-	-	Upgrade
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57	Upgrade
Debt / FCF Ratio	12.53	-	63.96	-	-	-	Upgrade
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17	Upgrade
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19	Upgrade
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23	Upgrade
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47	Upgrade
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%	Upgrade
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%	Upgrade
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%	Upgrade
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%	Upgrade
Earnings Yield	0.07%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%	Upgrade
FCF Yield	0.36%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%	Upgrade
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.